Avelos Therapeutics Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Start-Up Nosis Partners Its AI Pl

Amid continued weakness in general investor sentiment around initial public offerings (IPOs) and venture capital (VC) financings in the sector, South Korean biopharma companies increasingly opted for

Two new venture capital funds based outside of the US together offer $365m for life science start-ups, including Amplitude Ventures’ second fund and XGEN Venture’s inaugural fund. Montreal-based Ampli

South Korean bioventure funding remained weak in the third quarter, with venture capital investment in the sector falling further from the previous three months, although a handful of companies manage